These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25156145)

  • 1. Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.
    Kim SY; Lee DH; Song X; Bartlett DL; Kwon YT; Lee YJ
    Apoptosis; 2014 Nov; 19(11):1603-15. PubMed ID: 25156145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death.
    Kim SY; Song X; Zhang L; Bartlett DL; Lee YJ
    Biochem Pharmacol; 2014 Mar; 88(2):178-88. PubMed ID: 24486574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Bcl-xL in synergistic induction of apoptosis by mapatumumab and oxaliplatin in combination with hyperthermia on human colon cancer.
    Song X; Kim SY; Lee YJ
    Mol Cancer Res; 2012 Dec; 10(12):1567-79. PubMed ID: 23051936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
    Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
    Lim DY; Park JH
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B
    Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.
    Sinicrope FA; Penington RC; Tang XM
    Clin Cancer Res; 2004 Dec; 10(24):8284-92. PubMed ID: 15623604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK-Bcl-2/Bcl-xL-Bax/Bak Pathway Mediates the Crosstalk between Matrine-Induced Autophagy and Apoptosis via Interplay with Beclin 1.
    Yang J; Yao S
    Int J Mol Sci; 2015 Oct; 16(10):25744-58. PubMed ID: 26516844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of AMP-activated protein kinase in cross-talk between apoptosis and autophagy in human colon cancer.
    Song X; Kim SY; Zhang L; Tang D; Bartlett DL; Kwon YT; Lee YJ
    Cell Death Dis; 2014 Oct; 5(10):e1504. PubMed ID: 25356873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.
    Zhu H; Guo W; Zhang L; Wu S; Teraishi F; Davis JJ; Dong F; Fang B
    Cancer Biol Ther; 2005 Jul; 4(7):781-6. PubMed ID: 16082182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.
    Song X; Dilly AK; Choudry HA; Bartlett DL; Kwon YT; Lee YJ
    Mol Cancer Res; 2015 Dec; 13(12):1533-43. PubMed ID: 26354682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosis.
    Song X; Dilly AK; Kim SY; Choudry HA; Lee YJ
    Cell Death Dis; 2014 Jun; 5(6):e1281. PubMed ID: 24901052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for two modes of synergistic induction of apoptosis by mapatumumab and oxaliplatin in combination with hyperthermia in human colon cancer cells.
    Song X; Kim SY; Lee YJ
    PLoS One; 2013; 8(8):e73654. PubMed ID: 24013390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells.
    Song X; Kim HC; Kim SY; Basse P; Park BH; Lee BC; Lee YJ
    J Cell Biochem; 2012 May; 113(5):1547-58. PubMed ID: 22174016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
    Gillissen B; Wendt J; Richter A; Richter A; Müer A; Overkamp T; Gebhardt N; Preissner R; Belka C; Dörken B; Daniel PT
    J Cell Biol; 2010 Mar; 188(6):851-62. PubMed ID: 20308427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
    Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
    Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells.
    Huang S; Sinicrope FA
    Cancer Res; 2008 Apr; 68(8):2944-51. PubMed ID: 18413764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.